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Aortic valve stenosis (AS) is the most common 
valvular disease pathology in developed countries 
affecting over 5% of the population over the age 
of 75 [1]. Age is also the most significant risk fac-
tor in the development of aortic stenosis. As the 
global population ages [2], AS rates will continue 
to increase around the world. Some of the chal-
lenges that have surfaced in AS management are 
appropriate diagnosis of stenosis severity and tim-
ing of intervention. Patients who develop severe 
AS are monitored closely for the development of 
symptoms or the development of left ventricle (LV) 
function decline. International guidelines [3, 4] 
currently recommend intervention for severe AS 
once symptoms develop or when there is a decline 
in LV ejection fraction (LVEF). As the LV faces an 
increasing load from the fixed valve obstruction, it 
is critical that a decline in LV systolic function is 
not missed. Once missed, the risk of intervention 
for severe AS rises sharply.
In the present study, Hita et al. [5] demon-
strate the use of LV diastolic function and increase 
in LV end-diastolic pressure (LVEDP) as mark-
ers of LV systolic function decline in patients 
with symptomatic AS. Twenty-six symptomatic 
patients with severe AS were evaluated prior to 
cardiovascular surgery with echocardiography 
and invasive catheterization. Patients with normal 
LVEDP (less than 15 mm Hg) were compared to 
patients with elevated LVEDP (over 15 mm Hg). 
Patients with elevated LVEDP were further subdi-
vided into without coronary artery disease (CAD) 
or with CAD. Their data show that patients with 
increased LVEDP also had LV stiffness, measured 
as a ratio of LV pressure to LV end diastolic vol-
ume, and lower systolic longitudinal strain. They 
also showed that these hemodynamic changes 
were associated with histologic changes includ-
ing a higher myocyte cross sectional and collagen 
volume. These findings suggest that severe AS 
with compensated LV function, defined by normal 
LVEDP, is hemodynamically and structurally dif-
ferent from decompensated severe AS.
This work has limitations including the small 
patient sample size. The study had 26 patients with 
7 patients in two groups and 12 in the third group. 
Further, there were significant differences in the 
aortic valve gradient between the groups, which 
may independently account for the differences 
observed in LVEDP and LV stiffness or diastolic 
function.
This paper supports the concept that using 
LVEF to monitor LV systolic function may be too 
blunt a tool to guide the timing of intervention for 
severe AS. This study’s findings are in keeping with 
the work of other researchers who have proposed 
the use of 2-dimensional (2D) longitudinal LV strain 
[6, 7] as a marker of future systolic dysfunction, in 
patients with severe AS, when LVEF is still pre-
served. Early identification of declining LV function 
is an important concern that is necessary in many 
areas of current medical care. These findings may 
be generalized to the monitoring of LV function in 
a wide range of conditions such as other valvular 
heart disease, like mitral regurgitation, side effects 
of chemotherapeutic agents, and degenerative 
cardiomyopathies.
This work raises the interesting question 
of whether we need to shift our focus to earlier 
diagnosis of impending LV dysfunction, instead of 
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ventions. The most appropriate tools to diagnose 
impending LV dysfunction are still to be defined. 
The use of LVEDP, LV diastolic function, and 2D 
strain have all been explored in this setting. Fur-
ther work is being done on the added value of 3D 
echocardiography for LV volume and function as-
sessments. With this paper, authors Hita et al. [5] 
have added an interesting layer to this discussion.
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